Meet Peter McNamara, Ph.D., Tectonic’s SVP, Head of Research
GPCR News
Sosei Heptares Announces Antitrust Clearance of License Agreement with Neurocrine Biosciences
Addex Raises $10 Million In Equity Financing
Trevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic Pain
Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed...
VIB spin-off Confo Therapeutics Enters Collaborative Agreement with Regeneron
Crinetics Pharmaceuticals announced the formation of an independently operated new company...
Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist
Neurocrine Biosciences Announces Positive Phase 3 Data for KINECT-HD Study Evaluating Valbenazine...
First in Human: Early-stage COVID therapies hold promise against omicron variant
OMass Therapeutics's founder, Carol Robinson, has been awarded the prestigious Louis-Jeantet ...
Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop ...
New structural perspectives in G protein-coupled receptor-mediated Src family kinase activation
Dr. Peter Robert Banks - Dr. GPCR Podcast
Dr. Adriano Marchese - Dr. GPCR Podcast
Automated micro-plate-based methods for quantifying GPCR activation
Dr. JoAnn Trejo - Dr. GPCR Podcast
Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
Dr. Kevin Pfleger and Dr. Elizabeth Johnstone were awarded one of the 2022 Diabetes Research...
Dr. Thomas P. Sakmar receives an honorary doctorate from Karolinska Institute